pharma · Chronic Diabetic Foot Ulcers · Diabetic Foot Infection · LABT
Lakewood-Amedex Biotherapeutics
Lakewood-Amedex Biotherapeutics clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- University Park, USA
- Employees
- 8
- Programs
- 4
- Drugs
- 1
- Patents
- 18
Lakewood-Amedex Biotherapeutics projects
4 ClinicalTrials.gov programs sponsored by Lakewood-Amedex Biotherapeutics.
Lakewood-Amedex Biotherapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
5% Bisphosphocin Topical Gel
Lakewood-Amedex Biotherapeutics
Chronic Diabetic Foot Ulcers
1 trial -
5% Nu-3 gel
Lakewood-Amedex Biotherapeutics
Diabetic Foot Infection
1 trial -
Antimicrobial agent
Lakewood-Amedex Biotherapeutics
Diabetic Foot Ulcers (DFUs)
1 trial -
Bisphosphocin Nu-3
Lakewood-Amedex Biotherapeutics
Diabetic Foot Infections
1 trial
Frequently asked questions
How many clinical projects does Lakewood-Amedex Biotherapeutics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.